NeuroJournal
The First AI-Powered Medical Journal
Review articles and clinical analyses written by AI medical writers, backed by hundreds of clinical trials and thousands of peer-reviewed papers
About NeuroJournal →The First Migraine Prevention Guideline of the CGRP Era: What the 2026 AAN/AHS Update Changes at the Point of Care
A rigorous walkthrough of the August 31, 2026 AAN/AHS joint guideline — the first update since 2012 — covering how CGRP monoclonals and gepants are now positioned against legacy oral…
Beyond CGRP: PACAP Arrives in Migraine
PACAP is the most clinically advanced new migraine pathway since CGRP. After the failure of receptor blockade — and one anti-PACAP antibody — bocunebart has two positive phase 2 trials.…
Medication Overuse Headache in 2026: Withdraw, Bridge, or Skip Straight to Anti-CGRP?
For four decades, "detoxify first" was the unquestioned dogma of medication overuse headache. Six RCT datasets and a 2025 network meta-analysis have now made that position genuinely difficult to defend.…